P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00408-020-00377-8.pdf
Reference68 articles.
1. Hsiao C-J, Cherry DK, Beatty PC et al (2010) National ambulatory medical care survey: 2007 summary. Natl Health Stat Report 27:1–32
2. Dicpinigaitis PV, Morice AH, Birring SS et al (2014) Antitussive drugs—past, present, and future. Pharmacol Rev 66:468–512
3. Irwin RS, French CL, Chang AB et al (2018) Classification of cough as a symptom in adults and management algorithms: chest guideline and expert panel report. Chest 153:196–209
4. Morice AH, Millqvist E, Bieksiene K et al (2020) ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. https://doi.org/10.1183/13993003.01136-2019
5. Morice AH, Millqvist E, Belvisi MG et al (2014) Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 44:1132–1148
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The discovery and development of gefapixant as a novel antitussive therapy;Expert Opinion on Drug Discovery;2024-08-13
2. Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist;Purinergic Signalling;2024-05-25
3. Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men;British Journal of Clinical Pharmacology;2024-05-22
4. Inhaled Corticosteroids for Chronic Cough: Yes or FeNO?;Lung;2024-05-11
5. Single‐ and Multiple‐Dose Pharmacokinetics of Gefapixant (MK‐7264), a P2X3 Receptor Antagonist, in Healthy Adults;The Journal of Clinical Pharmacology;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3